Potential conflict of interest: E.M.H. has received research funding from AstraZeneca and Bristol-Myers Squibb and honoraria from Bayer. R.C.B. has received research funding from AstraZeneca, Bayer, Bristol-Myers Squibb, Johnson & Johnson, Medicines Company, Regado Biosciences, and Schering-Plough Research Institute.
Atrial fibrillation and stroke severity: Expanding the mechanistic exemplar, clinical phenotype, and goals of anticoagulant pharmacotherapy†
Version of Record online: 9 DEC 2008
Copyright © 2008 American Neurological Association
Annals of Neurology
Volume 64, Issue 5, pages 480–483, November 2008
How to Cite
Hylek, E. M. and Becker, R. C. (2008), Atrial fibrillation and stroke severity: Expanding the mechanistic exemplar, clinical phenotype, and goals of anticoagulant pharmacotherapy. Ann Neurol., 64: 480–483. doi: 10.1002/ana.21551
- Issue online: 9 DEC 2008
- Version of Record online: 9 DEC 2008
Options for accessing this content:
- If you are a society or association member and require assistance with obtaining online access instructions please contact our Journal Customer Services team.
- If your institution does not currently subscribe to this content, please recommend the title to your librarian.
- Login via other institutional login options http://onlinelibrary.wiley.com/login-options.
- You can purchase online access to this Article for a 24-hour period (price varies by title)
- If you already have a Wiley Online Library or Wiley InterScience user account: login above and proceed to purchase the article.
- New Users: Please register, then proceed to purchase the article.
Login via OpenAthens
Search for your institution's name below to login via Shibboleth.
Registered Users please login:
- Access your saved publications, articles and searches
- Manage your email alerts, orders and subscriptions
- Change your contact information, including your password
Please register to:
- Save publications, articles and searches
- Get email alerts
- Get all the benefits mentioned below!
Patients and/or caregivers may access this content for use in relation to their own personal healthcare or that of a family member only. Terms and conditions will apply.